Apollo Hospitals to Buy IFC’s 31% Stake in Apollo Health for ₹1,254 Crore

Apollo Hospitals Enterprise Ltd (AHEL) has announced it will acquire the International Finance Corporation’s (IFC) 31% stake in Apollo Health and Lifestyle Ltd (AHLL) for ₹1,254 crore, as per recent reports. Following the transaction, Apollo will hold 99.42% in AHLL, with the remaining 0.58% under the employee stock option plan.

The acquisition is expected to be completed by November 2025. The deal is subject to approval from the Competition Commission of India.

Subsidiary Profile

Apollo Health and Lifestyle operates across several healthcare segments, including diagnostics, primary care, birthing and women’s health, dental services, dialysis, and ambulatory care. In FY25, the company reported a consolidated turnover of ₹1,553.5 crore.

Investment in Gurugram Centre

Separately, the Apollo board has approved an investment of ₹573 crore to set up a new oncology centre in Gurugram. The facility will include the Proteus One Proton Beam Therapy system and will be able to treat an additional 350 cancer patients each year.

Cancer Care Expansion

The Gurugram facility will provide treatments in areas such as proton therapy, robotic surgery, linear accelerators, immunotherapy, targeted therapies, and genomics-based medicine. It will also offer bone marrow transplants and CAR T-cell therapies. The centre is part of the second phase of Apollo’s expansion in Gurugram and is expected to be operational in four years.

Apollo has stated that it intends to double its oncology business to over ₹5,000 crore in the next 3 to 4 years. The expansion will be supported by new facilities and a wider presence in major cities.

Read more: Apollo Hospitals Stake Sale Confirmation: 1.3% Stake Sold via Block Deal!

Apollo Hospitals Share Price Performance

As of September 15, 2025, 10:50 AM, Apollo Hospitals Enterprise share price was trading at ₹7,836.00, a 0.49% from the previous close.

Conclusion

With the acquisition of IFC’s stake in AHLL and new investments in oncology, Apollo Hospitals is consolidating its operations while adding capacity in specialised healthcare.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.